C2N Diagnostics Is A Specialty Diagnostics Company Dedicated To Improving Brain Health Through Advanced Biomarker Technologiesfounded By Drsdavid Holtzman And Randall Bateman From Washington University School Of Medicinethecompany Operates A Clia Certified And Cap Accredited Clinical Laboratory In Stlouismissouri C2N Focuses On Enhancing Theearly Diagnosis And Treatment Of Alzheimeraes Diseaseand Related Neurodegenerativedisordersits Flagship Producttheprecivityada C Blood Testaccurately Detects Brain Amyloid Plaques Associated With Alzheimeraesproviding A Non Invasivealternativeto Traditional Diagnostic Methodsthecompany Also Offers Biomarker Services That Support Clinical Trials By Facilitating Patient Enrollment And Monitoring Treatment Responsesc2N Collaborates With Various Pharmaceutical Companiesacademic Institutionsand Nonprofitscontributing To Over 150 Alzheimeraes Studies Worldwide
